Clinical research - Press Releases

Date	Title	Company
12-Nov-2019	Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech	Parkinson’s Foundation
11-Nov-2019	New data show non-inferiority of efficacy for subcutaneous formulation of CT-P13 (biosimilar infliximab) to intravenous formulation of CT-P13 in people with rheumatoid arthritis	Celltrion Healthcare
11-Nov-2019	First Phase 3 results from DISCOVER studies evaluating Tremfya in Psoriatic Arthritis	The Janssen Pharmaceutical Companies
11-Nov-2019	Photothermal Spectroscopy Corp and Bio-Rad Form Partnership in the Field of Simultaneous IR and Raman Spectroscopy	Bio-Rad Laboratories, Inc
11-Nov-2019	F2G Receives US FDA Breakthrough Therapy Designation for Olorofim	F2G Ltd
11-Nov-2019	evitria Opens its New Head Office in Scandinavia	evitria AG
11-Nov-2019	Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment	ABCAM PLC
11-Nov-2019	GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy	GW Pharmaceuticals plc
11-Nov-2019	ASLAN PHARMACEUTICALS ANNOUNCES TOPLINE RESULTS FROM TREETOPP GLOBAL PIVOTAL STUDY OF VARLITINIB IN BILIARY TRACT CANCER	ASLAN Pharmaceuticals
11-Nov-2019	UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP	UCB
11-Nov-2019	Autolus Therapeutics Presents Preclinical Data on AUT06NG at the SITC Annual Meeting	Autolus Therapeutics plc
11-Nov-2019	Roxadustat Phase III programme pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease	AstraZeneca
11-Nov-2019	World’s First Cyclic IMS Mass Spectrometer Installed at Aston University	Aston University
11-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
11-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults	Mallinckrodt
11-Nov-2019	Peripheral I.V. Catheter Market Analysis by Sales, Revenue, Production and Consumption Forecast to 2022	P&S Intelligence
08-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
08-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in	Mallinckrodt plc
08-Nov-2019	Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions	Daiichi Sankyo
08-Nov-2019	Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen	Bavarian Nordic A/S